Search all medical codes

Injection, belimumab, 10 mg

HCPCS code

Name of the Procedure:

Injection, belimumab, 10 mg (J0490)

Common Names: Belimumab injection, Benlysta injection
Technical/Medical Terms: Monoclonal antibody therapy, biologic agent injection

Summary

Belimumab is a medication given by injection to help manage autoimmune conditions, especially Systemic Lupus Erythematosus (SLE). It works by targeting and inhibiting certain proteins in the immune system that cause inflammation and tissue damage.

Purpose

Medical Conditions or Problems:
  • Systemic Lupus Erythematosus (SLE)
  • Lupus Nephritis
Goals:
  • Reduce disease activity
  • Prevent flare-ups
  • Improve quality of life by decreasing symptoms like pain and fatigue

Indications

Specific Symptoms or Conditions:
  • Persistent, active SLE despite standard therapy
  • Autoimmune-driven inflammation not adequately controlled by other treatments
Patient Criteria:
  • Diagnosed with SLE or lupus nephritis
  • Adults and children aged 5 years and older

Preparation

Pre-Procedure Instructions:
  • No specific fasting requirements
  • Inform your doctor about all medications and supplements you're taking
  • Schedule any necessary blood tests your doctor may recommend to check your health status
Diagnostic Tests/Assessments:
  • Comprehensive blood count (CBC)
  • Serum creatinine and urine protein tests
  • Other baseline labs to monitor liver and kidney function

Procedure Description

  1. Initial Assessment: Healthcare providers assess your vital signs and review your medical history.
  2. Preparation: The site for the injection (usually the upper arm, thigh, or abdomen) is cleaned with an antiseptic wipe.
  3. Injection: Using a syringe, a healthcare professional administers the belimumab injection subcutaneously or intravenously.
    • Subcutaneous Injection: It’s injected just under the skin.
    • Intravenous Infusion: Belimumab is given through a vein over about an hour.
  4. Observation: After the injection, the patient might be observed for a short period for any immediate allergic reactions or side effects.
Tools/Equipment:
  • Syringe and needle for subcutaneous injection
  • IV setup for intravenous infusion
  • Antiseptic wipes, bandages
Anesthesia/Sedation:
  • Not typically required but mild sedation can be used if the patient is anxious or in pain.

Duration

  • Subcutaneous injection: A few minutes
  • Intravenous infusion: Approximately 1 hour

Setting

  • Can be performed in an outpatient clinic, hospital, or specialized infusion center.

Personnel

  • Registered Nurse (RN) or healthcare provider trained in injections and infusions
  • Doctor for supervision and immediate medical care

Risks and Complications

Common Risks:
  • Injection site reactions (pain, redness, swelling)
  • Mild allergic reactions (rash, itching)
Rare Risks:
  • Severe allergic reactions or anaphylaxis
  • Infections due to immune suppression
Possible Complications:
  • Management involves antihistamines for mild reactions, or epinephrine and emergency medical care for severe reactions.

Benefits

  • Alleviation of lupus symptoms may begin to be noticed within a few weeks to months.
  • Reduces frequency and severity of disease flare-ups.
  • Improved overall quality of life.

Recovery

Post-Procedure Care:
  • Monitor the injection site for any adverse reactions.
  • Normal activities can usually be resumed immediately unless otherwise directed by your doctor.
Expected Recovery Time:
  • Minimal to no downtime required, though some patients may experience mild fatigue.
Follow-Up:
  • Regular follow-up visits to monitor efficacy and side effects.
  • Routine blood tests to ensure normal organ function.

Alternatives

Other Treatment Options:
  • Standard medications like corticosteroids, antimalarials (e.g., hydroxychloroquine), and immunosuppressive drugs (e.g., methotrexate).
Pros and Cons of Alternatives:
  • Standard medications may not be as targeted but can be effective and less costly.
  • May require more frequent administration and have different side effect profiles.

Patient Experience

During the Procedure:
  • Minor discomfort or pain at the injection site.
  • Feeling of a pinch during needle insertion.
After the Procedure:
  • Possible mild soreness at the injection site.
  • Usually no significant pain, easily managed with over-the-counter pain relief if needed.
Pain Management and Comfort:
  • Cold packs can be applied to the injection site to reduce swelling and discomfort.
  • Over-the-counter pain relievers may be used if approved by your doctor.

--- This markdown is created to help patients and caregivers understand the essentials of the HCPCS procedure code J0490, covering all relevant aspects from preparation to recovery. Always follow detailed instructions and guidance from your healthcare provider.

Medical Policies and Guidelines for Injection, belimumab, 10 mg

Related policies from health plans

Similar Codes